Large amounts of type II-secreted phospholipase A 2 (type II sPLA 2 ) are secreted into inflammatory synovial fluid and they are believed to induce the synthesis of lipid mediators by articular chondrocytes. Preliminary experiments showed that insulin-like growth factor-I, which counteracts cartilage degradation in arthritis, inhibits interleukin-1  -induced type II sPLA 2 gene expression in rabbit articular chondrocytes (Berenbaum, F., G. Thomas, S. Poiraudeau, G. Béré-ziat, M.T. Corvol, and J. Masliah. 1994. FEBS Lett. 340: 51-55). The present study showed that IL-1  induced the sustained synthesis of prostaglandin E 2 and a parallel increase in type II sPLA 2 gene expression (assessed by enzymatic activity and Northern blot analysis), but no increase in cytosolic PLA 2 gene expression (assessed by Northern and Western blot analysis) or cytosolic PLA 2 activity in rabbit articular chondrocytes. IGF-I inhibited both IL-1  -stimulated PGE 2 synthesis and type II sPLA 2 gene expression, but had no effect on cytosolic PLA 2 gene expression. Nuclear run-on experiments revealed that IL-1  stimulated the transcription rate of type II sPLA 2 gene, giving rise to longlived mRNA in cells treated with actinomycin D. IGF-I did not affect transcription rate, suggesting that it acts as a post-transcriptional step. Sucrose density gradient analysis of the translation step showed no effect of IGF-I on the entry of type II sPLA 2 mRNA into the polysomal pool or on its distribution into the various polysomal complexes, suggesting that IGF-I does not act on the translation of the mRNA. Lastly, IGF-I strongly decreased the half-life of IL-1  -induced type II sPLA 2 mRNA (from 92 to 12 h), suggesting that IGF-I destabilizes mRNA. These data demonstrate that IL-1  stimulates the transcription rate of the type II sPLA 2 gene and gives rise to a very stable mRNA. In contrast, IGF-I decreases the half-life of the type II sPLA 2 message. (